{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:02:10Z","timestamp":1786424530366,"version":"build-2736575974"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.18632\/oncotarget.24732","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T10:21:41Z","timestamp":1522664501000},"page":"17430-17442","source":"Crossref","is-referenced-by-count":30,"title":["Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis"],"prefix":"10.18632","volume":"9","author":[{"given":"Joy","family":"Cuenco","sequence":"first","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Wehnert","sequence":"additional","affiliation":[{"name":"Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, 30625, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Blyuss","sequence":"additional","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kazarian","sequence":"additional","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"Whitwell","sequence":"additional","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dawnay","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, University College London Hospitals NHS Foundation Trust, London, W1T 4EU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[{"name":"Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, 30625, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London, Royal Free Hospital, London, NW3 2PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Timms","sequence":"additional","affiliation":[{"name":"Institute for Women's Health, University College London, London, WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Taylor-Robinson","year":"2005","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.bjc.6603127","article-title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001","volume":"94","author":"Aithal","year":"2006","journal-title":"Br J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998","volume":"48","author":"Thomas","year":"2001","journal-title":"Gut"},{"key":"5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Abou-Alfa","year":"2008","journal-title":"Ann Surg"},{"key":"6","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1136\/gut.2007.138859","article-title":"Cholangiocarcinoma and its management","volume":"56","author":"Taylor-Robinson","year":"2007","journal-title":"Gut"},{"key":"7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/13651820701504207","article-title":"Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study","volume":"9","author":"Chattopadhyay","year":"2007","journal-title":"HPB (Oxford)"},{"key":"8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/j.1572-0241.2007.01333.x","article-title":"Comparison of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in the diagnosis of pancreatobiliary diseases: a prospective study","volume":"102","author":"Bordas","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gie.2008.10.036","article-title":"Early detection of extrahepatic bile-duct carcinomas in the nonicteric stage by using MRCP followed by EUS","volume":"70","author":"Maehara","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1542-3565(04)00006-0","article-title":"A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures","volume":"2","author":"Kipp","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1572-0241.2004.30845.x","article-title":"Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation","volume":"99","author":"Salomao","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Gores","year":"2006","journal-title":"Gastroenterology"},{"key":"13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gie.2010.08.050","article-title":"Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience","volume":"73","author":"Al-Haddad","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"Meier","year":"2006","journal-title":"Endoscopy"},{"key":"15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.gie.2011.04.016","article-title":"Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos)","volume":"74","author":"Costamagna","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1517\/17530059.2013.826646","article-title":"Novel diagnostic and prognostic biomarkers in biliary tract cancer","volume":"7","author":"Pereira","year":"2013","journal-title":"Expert Opin Med Diagn"},{"key":"17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(08)70027-5","article-title":"Circulating markers of biliary malignancy: opportunities in proteomics?","volume":"9","author":"Banks","year":"2008","journal-title":"Lancet Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-2004-828891","article-title":"Serum and bile markers for cholangiocarcinoma","volume":"24","author":"Klump","year":"2004","journal-title":"Semin Liver Dis"},{"key":"19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Lindor","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/cncr.20469","article-title":"Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma","volume":"101","author":"Maitra","year":"2004","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/bjc.2011.376","article-title":"A combination of serum leucine-rich alpha-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures","volume":"105","author":"Pereira","year":"2011","journal-title":"Br J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3835(02)00691-2","article-title":"Serum MUC5AC mucin as a potential marker for cholangiocarcinoma","volume":"195","author":"Bhudhisawasdi","year":"2003","journal-title":"Cancer Lett"},{"key":"23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.canlet.2006.05.007","article-title":"A new mucin antibody\/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma","volume":"247","author":"Wongkham","year":"2007","journal-title":"Cancer Lett"},{"key":"24","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/sj.bjc.6604364","article-title":"MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer","volume":"98","author":"Pereira","year":"2008","journal-title":"Br J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.surg.2013.12.003","article-title":"A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC)","volume":"155","author":"Guglielmi","year":"2014","journal-title":"Surgery"},{"key":"26","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/sj.bjc.66010266601026","article-title":"Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer","volume":"88","author":"Nishiguchi","year":"2003","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0973-6883(11)60110-2","article-title":"Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer","volume":"1","author":"Pereira","year":"2011","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"28","first-page":"6663","article-title":"Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study","volume":"34","author":"Basso","year":"2014","journal-title":"Anticancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.dld.2008.11.010","article-title":"Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma","volume":"41","author":"Zhang","year":"2009","journal-title":"Dig Liver Dis"},{"key":"30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cncr.27611","article-title":"Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer","volume":"119","author":"Pereira","year":"2013","journal-title":"Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10620-014-3397-7","article-title":"Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures","volume":"60","author":"Parsi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/(SICI)1097-4644(19990315)72:4<483::AID-JCB4>3.0.CO;2-I","article-title":"c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation","volume":"72","author":"Hann","year":"1999","journal-title":"J Cell Biochem"},{"key":"33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000658-199803000-00012","article-title":"Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker","volume":"227","author":"Carty","year":"1998","journal-title":"Ann Surg"},{"key":"34","first-page":"15","article-title":"Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma","volume":"51","author":"Poovorawan","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"35","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/j.1572-0241.2007.01403.x","article-title":"Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy","volume":"102","author":"Shim","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","article-title":"Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response","volume":"382","author":"Inoue","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"37","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/cncr.11652","article-title":"Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma","volume":"98","author":"Pairojkul","year":"2003","journal-title":"Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10620-014-3472-0","article-title":"Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"60","author":"Yin","year":"2015","journal-title":"Dig Dis Sci"},{"key":"39","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Gores","year":"2014","journal-title":"J Hepatol"},{"key":"40","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study","volume":"337","author":"Seif","year":"2008","journal-title":"BMJ"},{"key":"41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Herod","year":"2009","journal-title":"Lancet Oncol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Feinstein","year":"1996","journal-title":"Journal of Clinical Epidemiology"},{"key":"43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(Sici)1097-0258(19960229)15:4<361::Aid-Sim168>3.0.Co;2-4","article-title":"Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Mark","year":"1996","journal-title":"Statistics in Medicine"},{"key":"44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Machine Learning"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:31:27Z","timestamp":1589038287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":44,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["24732","29707118"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24732","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]}}}